-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Assumes Sensei Biotherapeutics at Buy, Announces Price Target of $5

Benzinga·06/02/2025 13:33:23
Listen to the news
HC Wainwright & Co. analyst Matthew Kelsey assumes Sensei Biotherapeutics (NASDAQ:SNSE) with a Buy rating and announces Price Target of $5.